Bank Of America Corp Evoke Pharma Inc Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.43 - $0.62 $29 - $42
69 New
69 $0
Q2 2022

Aug 12, 2022
BUY
$2.04 - $10.32 $255 - $1,290
125 New
125 $0

Others Institutions Holding EVOK

# of Institutions
1
Shares Held
1.46K
Call Options Held
0
Put Options Held
0
View Full List

About Evoke Pharma Inc

EVOK Quotes by TradingView
  • Ticker EVOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,343,070
  • Market Cap $1.57M
  • Description
  • Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...
More about EVOK
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email